Sunstone Therapies

Sunstone Therapies Leading the research and delivery of psychedelic therapies for those affected by complex mental health challenges.

Sunstone Therapies is a first mover in the research and commercial delivery of psychedelic therapies for those touched by cancer and beyond.

Change can be hard to spot as it’s happening.In psychedelic-assisted therapy, it can show up in small ways: - meeting a ...
09/06/2026

Change can be hard to spot as it’s happening.

In psychedelic-assisted therapy, it can show up in small ways:
- meeting a hard conversation with less bracing,
- noticing what we want before anyone asks,
- saying no without rehearsing it first,
- or feeling a little more at home in ourselves.

Sometimes it becomes visible within the therapeutic relationship in how a participant connects, how present they are in the room, and how fully they seem able to engage with themselves and their therapist.

That kind of noticing takes attention and continuity, which is part of what the therapeutic relationship offers across the whole arc of this treatment, from preparation through the dosing session and integration afterward.

Here's how Sunstone therapist Sara So, LCPC, describes what therapists look for.

What will it take to make psychedelic-assisted therapy more accessible, without thinning the support around each person?...
09/03/2026

What will it take to make psychedelic-assisted therapy more accessible, without thinning the support around each person?

A study published in Frontiers in Psychiatry examined how different care models could affect clinician time, cost, and ultimately patient access. Sunstone contributed data from our psilocybin-assisted therapy study for people with cancer and major depression.

In the model they studied, each person is treated in their own room with their own therapist for the whole session. A supervising clinician oversees three to four rooms by video and steps in wherever support is needed.

That structure—compared to a 1:1 supervising clinician ration—was estimated to lower costs by about a third per person. The one-to-one therapist relationship in the room stays exactly the same. What changes is how many treatment rooms one supervising clinician can address.

As these therapies continue to be studied, access depends on care models that use a limited clinical workforce responsibly while keeping the structure and support people need.

Technical knowledge matters, and it always will. The therapists and physicians at Sunstone train for years, and that tra...
08/16/2026

Technical knowledge matters, and it always will. The therapists and physicians at Sunstone train for years, and that training is what makes psychedelic-assisted therapy possible to deliver safely.

There is also a part of medicine that is harder to teach and impossible to chart. It shows up in how a participant is met in a difficult moment, in the ability and willingness of a therapist to sit with what surfaces.

In our experience, it's often this relational aspect of the therapeutic process that stays with people long after the experience ends.

08/08/2026

We use the term "participant" intentionally.

Psychedelic-assisted therapy is not a passive experience. It can surface memories, emotions, and sensations long buried. While what surfaces varies from person to person, the therapy around it asks for active engagement in working with what comes up.

Eloise Cherian is one of the first people you'll speak with at Sunstone. Here's how she describes what participation involves and why our screening process is as thorough and intentional as it is.

Psilocybin is a classic psychedelic, known for producing shifts in perception, mood, and thinking.It binds to serotonin ...
08/06/2026

Psilocybin is a classic psychedelic, known for producing shifts in perception, mood, and thinking.

It binds to serotonin receptors in the part of the brain tied to rigid self-narrative and rumination. Researchers believe temporarily loosening this default mode network may open a window where old patterns feel less fixed.

Researchers have been studying whether that shift may help support therapeutic work in structured clinical settings.

At Sunstone Therapies, psilocybin is just one of the classic compounds being studied as part of psychedelic-assisted therapy research. While the medicine plays an important role, the broader therapeutic process matters just as much: preparation beforehand, support during treatment, and integration afterward.

The compound creates the conditions. What happens within this window is guided and supported by the therapy.

Learn more: https://www.sunstonetherapies.com/psychedelic-therapy/

Some experiences arrive with words. Others begin as a feeling, a memory, or a physical sensation that doesn't yet fit in...
07/24/2026

Some experiences arrive with words. Others begin as a feeling, a memory, or a physical sensation that doesn't yet fit into a story.

Often, it's only after returning home - when life resumes, and the dust begins to settle - that those experiences start to make sense.

Trauma-informed care honors that process. Therapists stay attentive to what is emerging, responding with curiosity rather than assumption and continuing the collaborative approach established during preparation. Consent remains ongoing. Preferences can change. Care adapts alongside the individual as their experience evolves.

At Sunstone, trauma-informed care isn't confined to the dosing day. It's reflected in every stage of the therapeutic process, helping build the trust, collaboration, and therapeutic relationship that support meaningful care.

07/21/2026

When it comes to the future of mental health care, Sunstone CEO Dr. Manish Agrawal sees a few things clearly. Current approaches largely manage symptoms. Psychedelic-assisted therapy, he believes, reaches the root cause beneath those symptoms to drive meaningful change.

Other questions remain open: namely, how PAT will integrate into mainstream care as research and regulation evolve.

What’s clear is that the work ahead is substantial, and the field is still building the evidence to understand its true impact.

What if participants had more say in how a clinical trial was experienced?That's one of the questions we're exploring at...
07/14/2026

What if participants had more say in how a clinical trial was experienced?

That's one of the questions we're exploring at Sunstone Therapies.

Through a shared decision-making framework, participants are invited into ongoing conversations about aspects of their PAT experience: from the therapeutic environment and facilitator preferences to the types of support that help them feel grounded throughout the process.

The protocol remains consistent, while the experience of it is personalized for each participant.

This approach is rooted in trauma-informed care and guided by a simple idea: trust grows through collaboration. By making space for participants' values, preferences, and lived experiences, we're exploring whether a more collaborative model can strengthen both care and research.

Understanding what works means studying both the intervention and how people experience it.

07/11/2026

Psychedelic-assisted therapy can act as something of a rehearsal space for life. A place where we can practice responding in different ways to how we have in the past. To meet challenging information with curiosity. Shame with self-compassion. Difficult decisions with openness.

The path is deeply individual. It unfolds as we walk it, shaped by our own willingness to stay with what comes up and to learn from it. That capacity is what we take with us from the therapy room to our relationships and our lives.

Here's how Sunstone therapist Jess Jones describes it.

Address

9905 Medical Center Drive Suite 350
Rockville, MD
20850

Alerts

Be the first to know and let us send you an email when Sunstone Therapies posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Contact The Business

Send a message to Sunstone Therapies:

Shortcuts

Featured

Share